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he acellular dermal matrix allograft has been used as an alternative to autogenous palatal mucosal graft. The aim of this
study was the evaluation of the biocompatibility of an acellular dermal matrix (AlloDerm®) in culture of macrophages. For
hydrogen peroxidase determination we used the method of Pick & Kesari, and the Griess method for nitric oxide determination,.
Statistical analysis showed no significant difference (p ≤ 0,05) in the release of nitric oxide and hydrogen peroxide by the
macrophages exposed to acellular dermal matrix and the negative control. The results suggest that acellular dermal matrix did
not activate the cell inflammatory response.
Uniterms: Dermal allograft; Macrophages; Nitric oxide; Hydrogen peroxide.
     matrix dérmica acelular tem sido utilizada como alternativa para a substituição de enxerto gengival autógeno. O objetivo
deste estudo foi avaliar a biocompatibilidade em cultura de células de macrófagos da matriz dérmica acelular (AlloDerm®).
Foram utilizados os métodos de Pick & Kesari, para a determinação da presença de peróxido de hidrogênio (H2O2) e de Griess
para a determinação de ácido nitroso (NO). Não houve diferença estatisticamente significante (p ≤ 0,05) no aumento da
presença de NO e H2O2 quando macrófagos foram expostos na presença da matrix dérmica acelular quando comparado com o
controle negativo. Pode-se concluir que a matrix dérmica acelular é biocompatível aos tecidos humanos.
Unitermos: Matriz dérmica; Macrófagos; Ácido nítrico; Peróxido de hidrogênio.
INTRODUCTION
Several techniques have been developed to solve
gingival aesthetic problems. The techniques can be grouped
as pediculated grafts and autogenous grafts (epithelial free
grafts and connective tissue graft)16,22. Aiming at reducing
the problems with these treatments, new techniques and
materials have been developed6,9,18-22,24,26,31.
A recent material developed for soft tissue grafting was
the acellular dermal matrix (AlloDerm®, Lifecore Biomedical,
Oral Restorative Division, Chaska,MN)1,6,25,30,32. This allograft
material has advantages to reduce surgical complications,
decrease donor site discomfort and improve esthetic tissue.
This graft is obtained from an allograft donor skin and
produced by a carefully controlled process that removes
the epidermis and dermis cells without altering the
extracellular matrix structure, reducing the possible immune
response and the transmission of diseases.
The need for biocompatible materials implies the
necessity of in vitro toxicity tests, animal experimentation
usage tests and clinical studies in humans23.The biological
system used in in vitro cytotoxicity testing of some materials
are cells in culture. Thus, culture of macrophage cells can
be used to evaluate the biocompatibility of materials. These
cells participate in many aspects of host defense,
inflammation and immunity, partly through their ability to
undergo adaptive responses to the conditions or stimuli
that prevail at sites to which they have been attracted2.
Among the numerous secretory products of
macrophages there are two groups of inorganic compounds
with a high degree of chemical reactivity: the ROI (including
super oxide, hydrogen peroxide, and in some populations
of mononuclear phagocytes, the products of
myeloperoxidase), and the RNI including nitrite (NO2
-) and
highly related reactive oxides such as nitric oxide and
nitrogen dioxide3.Macrophage-derived RNI are of interest
for at least three reasons: their production is under strict
immunological control27,28, they are synthesized by enzymes
novel to mammalian biochemistry, which have not been yet
well characterized13, and they appear to play an important
role in some of the carcinogenic13,15, antitumor12,29 and
antimicrobial7 actions of the activated macrophage.
Although Alloderm® is tested before being released for
sale; we assume that it is important to evaluate the
biocompatibility in macrophages culture.
MATERIAL  AND METHODS
This study was approved by the Institutional Committee
on Animal Research, School of Pharmaceutical Science.
Animals
The Animals Laboratory of the School of Pharmaceutical
Science, UNESP (State University of São Paulo) Araraquara,
SP, BRAZIL supplied six-week old male Swiss mice weighing
18 to 25 g.
Acellular dermal matrix samples
Samples of acellular dermal matrix (ADM), commercially
known as AlloDerm®, measuring 4x4 mm, from different
batches were obtained at the Department of Periodontology
of Araraquara Dental School UNESP-Araraquara, São Paulo,
Brazil.
Cell macrophage
Mice were injected i.p. 3 to 4 days before harvesting
with 3 ml of  thioglycollate broth. Macrophages were
obtained after killing the mice with chloroform, and the
peritoneum was exposed using sterile scissors. Saline
solution (0.85% NaCl) was introduced into the peritoneum
and after digital massage, the suspension was removed by
aspiration. This suspension of peritoneal cells and saline
was placed in a Neubauer chamber and counted in order to
obtain the ideal concentration for each test. The adherent
cells of PEC were re-suspended in RPMI-1640 medium at
concentration of 5_10 6 cells/ml, and 100ll of this suspension
was added to each well tissue dish along with 100 ll of a
10.0lg/ml (1.0lg) E. coli O111B lipopolysaccharide (LPS)
solution was used as positive control, or RPMI-1640 medium
as negative control. The cells were incubated for 24 h before
stimulation, and 50 ll aliquots of culture supernatant were
mixed with 50ll of Griess reagent (1% w/v sulphanylamide,
0.1% w/v naphthylethylenediamine and 3% H3PO4),
incubated at room temperature for 10 min, and the color
reaction was determined at 450 nm with a Multiskan Ascent
ELISA reader (Labsystems, Helsinki, Finland) Supernatants
from quadruplicate cultures were assayed in four experiments
and reported as the mean NO2 concentration ±SD.
NO2 release
Nitrite concentration in the medium was measured by a
micro plate assay method5. The Alloderm® was incubated
with cell suspension in a concentration of 5x106 cells / ml, at
37º C and atmosphere with CO2 5%. After 24 hs, 50mL aliquots
were removed from conditioned medium and incubated with
an equal volume of Griess reagent (1% sulfanilamide, 0.1%
naphthylethylene diamine dihidrochloride, 0.25% H3PO4) at
room temperature for 10 minutes. The absorbance at 550 nm
was determined in a micro plate reader. The tests were made
in quadruplicate and the results were expressed in micromoles
of NO / 5 x 105 peritoneal cells, from a standard curve
established in each test, constituted of known molar
concentrations of NO  in RPMI – 1640 medium.
H2O2 release
The method depends on the determination of hydrogen
peroxide (H2O2) release in the culture of peritoneal
macrophages from Swiss mice.  Suspensions of peritoneal
cells were performed using a concentration of 2 x 106 cells/
ml in a solution of phenol red, containing 140 mM NaCl, 10
mM potassium phosphate, pH 7.0; 5.5 mM dextrose; 0.56
mM phenol red and type II horseradish peroxidase 0.01 mg/
mL (Sigma). Aliquots of 0.1 m were transferred to culture
plates, flat bottomed containing 96 wells (Corning). The
acellular dermal matrix or 50 mL of Zymosan solution (5 mg/
ml, Sigma) were added to each well. The samples were
incubated for one hour at 37oC in a 5% CO2 atmosphere.
After the period of incubation, the reaction was interrupted
by addition of 10 mL of NaOH 4N. Experiments were done in
quadruplicate and the absorbance was determined in an
ELISA automatic photometer, with a 620 nm filter. The results
were expressed in nanomols of H2O2/2 x 10
5 peritoneal cells,
from a standard curve established in each test, constituted
of known molar concentrations of H2O2 in buffered phenol
red.
Statistical  Analysis
Comparisons between groups were performed using
Student’s T test. P values <0.05 were considered statistically
significant.
RESULTS
Figures 1 and 2 illustrate the release of nitric oxide and
hydrogen peroxide when macrophages were exposed to
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acellular dermal matrix, respectively. Statistical analysis
showed no significant difference (p ≤ 0.05) when compared
with negative control. However, the level of release of these
mediators in positive control was statistically different (p ≥
0.05).
DISCUSSION
This study evaluated the cell inflammatory response of
in vitro macrophages in contact with the acellular dermal
matrix measuring the release of nitric oxide and hydrogen
peroxide. The positive control using zymosan-SIGMA to
H2O2 release and LPS-SIGMA to NO release showed a high
potential of macrophages activation and liberation of H2O2
and NO, respectively. The acellular dermal matrix was not
able to stimulate macrophage liberation of hydrogen peroxide
(H2O2) and nitric oxide (NO).
In respect to these results we pointed out that Liversey,
et al.14 (1994) evaluating immunohistochemically the material
AlloDerm® did not find any antigen that could develop an
immune reaction.
Cellular events were evaluated in some human studies
with ADM grafts for root coverage4,10,11,33. In 1998, Harris10,
using acellular dermal matrix graft in treatment of gingival
recessions in patients, obtained complete root coverage on
two of three defects. In histological analysis, the AlloDerm®
had incorporated and became part of the gingival tissue in
the area. The same author11 in 2001 reported a comparative
clinical study of root coverage obtained with ADM versus
connective tissue. Biopsy of the grafted area revealed elastin
fibers. The author stated that the presence of these fibers
implied that the ADM was being incorporated into the host
tissue.
In a recent study Cummings, et al.4 (2005) histologically
evaluated the acellular dermal matrix graft. The findings of
the study showed new fibroblast, vascular elements, and
collagen were present throughout the ADM, with retention
of the transplanted elastin fibers.
All of these results can be directly related with the
laboratory processing of human skin obtained in tissue banks
with the removal of all cells without altering the connective
tissue structure, composed of type I collagen fibers14. In
this respect, the AlloDerm® matrix is rigorously controlled
by the FDA according to the guidelines of the American
Association of Tissue Banks. Apart from the selection of
possible donors, serologic and microbiologic exams are also
performed to screen for diseases such as AIDS, syphilis,
hepatitis, etc. The patented process of preparation and
lyophilization removes all cells, preserving the collagen
structure of the connective tissue. In the manufactured
controls, histological and immunohistochemistry tests are
carried out to check the complete removal of all cellular
components.
Within the limits of this study the present results show
that there was no release of hydrogen peroxide (H2O2) and
nitric oxide (NO), suggesting that the acellular dermal matrix
did not activate the cell inflammatory response, although
new studies should be accomplished with Alloderm® use.
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